Modeling research identifies potentially profitable bioproducts

// Chemical & Biological Engineering

Tags: Faculty, research

Photo of Christos Maravelias and Jennifer Reed

Chemical and biological engineering professors Christos Maravelias (left) and Jennifer Reed (right) collaborated on a recent publication identifying potentially profitable bioproducts. The study’s first author, Tony (Wenzhao) Wu, is pictured below. Photo credit: Matt Wisniewski and James Runde.

Share this story:

Imagine a new and improved biorefinery, one that produces advanced biofuels as environmentally sustainable as they are economically viable. In the biorefinery of the future, every step of the pipeline is optimized, almost every part of the energy crop is used, and the entire system, from field to fuel, serves to drive down carbon emissions.

As researchers at the Great Lakes Bioenergy Research Center (GLBRC) work toward that vision, they’re finding inspiration in what might seem an odd or unlikely place – the oil refinery. Oil refineries make an array of products from crude oil, including low-cost gasoline and high-value petrochemicals. The practice of making co-products alongside fuels helps improve the refinery’s bottom line and could also prove critical to the biorefinery’s economic model.

Photo of Tony (Wenzhao) Wu
Tony (Wenzhao) Wu. Photo credit: James Runde.

But what bioproducts should or could the future biorefinery produce alongside advanced biofuels? Which will succeed in making the process more economical? New work from GLBRC, published in Biotechnology and Bioengineering, is providing a much-needed framework for answering those questions, helping researchers to identify the most promising bio-based chemicals.

“We wanted to develop methods that will allow us to identify chemicals that will be promising in a biorefinery,” says Christos Maravelias, Vilas Distinguished Achievement Professor and Paul A. Elfers Professor of chemical and biological engineering at the University of Wisconsin–Madison. “This means taking into account what can be done biologically and also taking into account the price of chemicals in the market.”

Maravelias, along with Associate Professor Jennifer Reed, Harvey D. Spangler Faculty Scholar in chemical and biological engineering, and the study’s first author Tony (Wenzhao) Wu, has developed and used a multi-scale modeling process to identify 32 biochemicals as economically promising if maximum yields can be achieved, and 22 biochemicals if the maximum productivities can be achieved.

To come up with the list, the team first identified a candidate pool of chemicals that can be created directly from microorganisms, and thus do not require potentially costly chemical conversion steps. Next, they screened the pool based on profit margin, market volume, and market size, while also incorporating the total process cost into their evaluation, including the downstream separation cost.

“It doesn’t mean that if we produce that chemical today on an industrial scale, it will be profitable,” Wu says of the bioproducts identified. “But it means it can be profitable in the future if the microbial conversion yield and productivity can be increased drastically and low separation cost can be achieved.”

The work provides immediate guidance for microbiologists and chemical engineers, steering them toward the production of biochemicals most worthy of time and investigation. As Wu says, “we don’t want to use our valuable resources to study chemicals that don’t appear to be promising.” But it’s also a flexible framework for answering other complex questions about the biology and economics of specific biochemicals and can be used to conduct other customized screenings.

“This is a starting point,” says Wu, “a model that combines what we know to be true about the microbial processes that generate these chemicals with what we know about the economics. Our final goal is to inform future research.”

Author: Krista Eastman